Purchase Order HHSN302201600034P

This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) to DNA Genotek Inc., a for-profit manufacturer of goods. The $8,525.00 contract is for the delivery of 450 units of the ORG-500 ORAGENE, DISCOVER MAILABLE TUBE product at $18.50 per unit. The contract has an ultimate completion date of August 24, 2012. DNA Genotek Inc. is a subsidiary of Orasure Technologies Inc., which specializes in developing, manufacturing, and marketing oral fluid diagnostic products...

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Qiagen, LLC for $10,456.60 on August 16, 2016, with firm fixed price, no set-aside. Place of performance is Bethesda, Maryland. The order calls for molecular diagnostics consumables and reagents, including DNA/RNA extraction kits and related laboratory supplies. Ultimate completion date is December 22, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a purchase order to Qiagen, LLC on August 17, 2016, for $4,285.40 under a firm fixed-price arrangement. Performance is located in Bethesda, Maryland, with an ultimate completion date of December 23, 2020. No set-aside was applied to this order. The source does not specify the particular products or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $4,427.49 on December 1, 2017, with ultimate completion by December 31, 2018. No set-aside was applied. Place of performance is Bethesda, Maryland. The order procures scientific supplies or equipment typical of Life Technologies' federal portfolio, which includes laboratory instrumentation, reagents, and consumables for genomic research applications.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Bio Basic Canada Inc. for $1,834.68 on February 26, 2016. Performance is located in Bethesda, Maryland. The order carries a firm fixed price and no set-aside designation. Ultimate completion was scheduled for December 29, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $12,187.66 on August 21, 2020, for genotyping experiments. Performance is at Life Technologies' facility in Grand Island, New York. The order carries a firm fixed price and has an ultimate completion date of October 30, 2020. No set-aside category applies.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on November 28, 2017, with a ceiling value of $52,494.10 for genetic sequencing and genomic analysis technologies and services.</p> <p>Place of performance is Bethesda, MD 20892. The order was priced on a firm fixed-price basis with an ultimate completion date of September 2, 2020. No set-aside was used for this delivery order.</p>